A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma
Clinical trial NCT00718484 · UNKNOWN
Trial details
- NCT number
- NCT00718484
- Sponsor
- Alaunos Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2012-04-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.